Alvine Pharmaceuticals Obtains $21,500,000 Series A Financing

  • Feed Type
  • Date
    9/15/2009
  • Company Name
    Alvine Pharmaceuticals
  • Mailing Address
    75 Shoreway Rd. San Carlos, CA 94070
  • Company Description
    Alvine Pharmaceuticals, Inc., is a biopharmaceutical company dedicated to developing and commercializing therapeutics for the treatment of Celiac sprue.
  • Website
    http://www.alvinepharma.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $21,500,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    This funding will support the continued development of ALV003 as an innovative protease therapy for the treatment of celiac disease, and further our goal to be the leading company in this space.
  • M&A Terms
  • Venture Investor
    Panorama Capital
  • Venture Investor
    InterWest Partners
  • Venture Investor
    Prospect Venture Partners
  • Venture Investor
    Sofinnova Ventures
  • Venture Investor
    Flagship Ventures

By posting a comment, you agree to our terms and conditions.